NorthSea Therapeutics
Latest round
- Series C
Last raised
- Dec 2021
Total raised
- $150M
Investors
- 9
About NorthSea Therapeutics
V. operates as a clinical-stage biotechnology company specializing in the development of structurally engineered fatty acid therapeutics to treat metabolic, inflammatory, and fibrotic diseases.
Who invested in NorthSea Therapeutics
9 investors across 3 rounds
See all investors in NorthSea Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NorthSea Therapeutics
Who invested in NorthSea Therapeutics?
NorthSea Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NorthSea Therapeutics raised?
NorthSea Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NorthSea Therapeutics last raise money?
NorthSea Therapeutics's most recent round on record is a Series C, in Dec 2021.
What does NorthSea Therapeutics do?
NorthSea Therapeutics is a biotechnology company.
Where is NorthSea Therapeutics headquartered?
NorthSea Therapeutics is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like NorthSea Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at NorthSea Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like NorthSea Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.